Twenty cases (17 male and 3 female patients) of AR-type MATD were diagnosed with persistently high plasma Met concentrations and compound heterozygous or homozygous variants of MAT1A without other pathogenic genes in this metabolic disorder. This evidence concerns the gene MAT1A and Other metabolic disease.